Fang J.X.Giustino G.So K.C.Y.Stolz L.Marin-Cuartas M.Maznyczka A.Baron S.J.Khan J.M.Chen M.Taramasso M.Seshiah P.Denti P.Lee A.P.W.Calvert P.A.Swanns M.J.Rogers T.Singh G.D.Ailawadi G.Hausleiter J.George I.Borger M.A.Sievert H.Maisano F.Alfieri O.de Backer O.Wang D.D.McCabe J.M.Hahn R.T.Tang G.H.L.Villablanca P.A.Fang J.X.Giustino G.Chak-Yu So K.Stolz L.Marin-Cuartas M.Kang D.Y.Maznyczka A.Iwata J.Hamid N.Wong N.Baron S.J.Khan J.M.Chen M.Taramasso M.Zaid S.Goel K.Beneduce A.Alasnag M.Almajid F.Seshiah P.Khokhar A.Almarzooq Z.I.Khambhati J.Chaturvedi A.Sanina C.Chiang M.Liu X.Dawdy J.Zweig B.Parikh S.Jabri A.Lok Lai L.K.Garbi M.Hausleiter J.Urena M.Treede H.Kofidis T.Eng M.H.Denti P.Wong R.H.L.Sing-Fung Chui A.Kang-Yin Lee M.Wong E.C.Y.Wong I.Lam Y.Y.Jappar I.A.Kotit S.Surunchupakorn P.Powpuree K.Meemook K.Lee A.P.W.Faggi A.Chan J.L.K.Guerrero M.Karam N.Sharma R.P.Poon K.Eeckhout E.Khalique O.K.Mackensen G.B.George I.Madhavan M.V.Ohno Y.Hayashida K.Sugiura A.Asgar A.W.Lim Y.Kuntjoro I.Fatt Hon J.K.Kong W.K.F.Mahidol University2026-06-142026-06-142026-05-11Jacc Cardiovascular Interventions Vol.19 No.9 (2026) , 1071-108619368798https://repository.li.mahidol.ac.th/handle/123456789/117277Mitral valve transcatheter edge-to-edge repair (M-TEER) is an established treatment option for patients with severe mitral regurgitation (MR) at high risk for surgery. However, the rate of recurrent MR ≥ 3+ after M-TEER may be up to 10% at 1 year. As the volume of M-TEER procedures increases, the number of patients experiencing recurrent MR post-TEER is also rising. M-TEER reshapes valve anatomy and complicates further treatment strategies for MR. In this review, the authors provide practical management considerations for patients with residual or recurrent MR after M-TEER.MedicineReviewSCOPUS10.1016/j.jcin.2026.02.0452-s2.0-1050388101761876760542120115